Theravance Reviews

5 Reviews
5 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Theravance President, CEO, and Director Rick E. Winningham
Rick E. Winningham
3 Ratings


    • Comp & Benefits
    • Work/Life Balance
    • Culture & Values
    • Career Opportunities
    Former Employee - Anonymous Employee
    Former Employee - Anonymous Employee

    I worked at Theravance


    Great place to work; competitive; good work environment


    Top heavy; few opportunities for growth

    Approves of CEO

Theravance Interviews

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty



  1. 1 person found this helpful  

    Pharmacology Interview

    Anonymous Employee  in  San Francisco, CA
    Anonymous Employee in San Francisco, CA
    Application Details

    I applied through a recruiter. The process took a day - interviewed at Theravance in May 2010.

    Interview Details

    30 min interview at professional meeting. Invited for onsite interview. Flew into area, stayed over night, and had full interview the following day. It consisted of a few 1:1 and a couple of group interviews and I gave a presentation

    Interview Questions
    • Why i felt I was equipped to handle the job without having a postdoc or post PhD work experience   View Answer
    No Offer
    Neutral Experience
    Average Interview

Theravance Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Edit Profile
Headquarters South San Francisco, CA
Size 150 to 499 Employees
Founded 1996
Type Company - Public (THRX)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year

Theravance figures there's no sense in re-inventing the wheel. The biotechnology firm takes aim at already proven biological targets, taking advantage of previous years of research to create more effective, next-generation treatments. Its development programs focus on respiratory disease, bacterial infections, and gastrointestinal and neurological conditions. Its sole marketed product, VIBATIV (an injectable antibiotic approved to treat skin infections and hospital-acquired pneumonia) was successfully developed and commercialized with partner Astellas. In an exclusive... More

Worked for Theravance? Contribute to the Community!